Gregory Fraser
Stock Analyst at Truist Securities
(2.72)
# 1,859
Out of 5,124 analysts
39
Total ratings
57.14%
Success rate
17.21%
Average return
Main Sectors:
Stocks Rated by Gregory Fraser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Hold | $77 → $90 | $78.43 | +14.75% | 11 | Oct 9, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $200 → $205 | $173.15 | +18.39% | 2 | Aug 28, 2025 | |
| BHC Bausch Health Companies | Maintains: Hold | $8 → $7 | $7.21 | -2.91% | 2 | Jul 25, 2024 | |
| XAIR Beyond Air | Maintains: Buy | $200 → $160 | $0.79 | +20,181.40% | 6 | Apr 30, 2024 | |
| BTMD biote | Maintains: Buy | $10 → $9 | $2.47 | +264.37% | 2 | Jan 18, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6 → $7 | $12.66 | -44.71% | 4 | Nov 8, 2023 | |
| CORT Corcept Therapeutics | Maintains: Hold | $26 → $29 | $38.20 | -24.08% | 5 | Aug 3, 2023 | |
| NVCR NovoCure | Reiterates: Buy | $95 | $13.12 | +624.09% | 3 | Jun 6, 2023 | |
| EOLS Evolus | Maintains: Buy | $14 → $18 | $6.72 | +167.86% | 2 | May 26, 2023 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $45 → $40 | $29.00 | +37.93% | 2 | May 26, 2023 |
ANI Pharmaceuticals
Oct 9, 2025
Maintains: Hold
Price Target: $77 → $90
Current: $78.43
Upside: +14.75%
Jazz Pharmaceuticals
Aug 28, 2025
Maintains: Buy
Price Target: $200 → $205
Current: $173.15
Upside: +18.39%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $7.21
Upside: -2.91%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $200 → $160
Current: $0.79
Upside: +20,181.40%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $2.47
Upside: +264.37%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $12.66
Upside: -44.71%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26 → $29
Current: $38.20
Upside: -24.08%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $13.12
Upside: +624.09%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14 → $18
Current: $6.72
Upside: +167.86%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45 → $40
Current: $29.00
Upside: +37.93%